Galectin Therapeutics
GALT
GALT
49 hedge funds and large institutions have $12.5M invested in Galectin Therapeutics in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 7 closing their positions.
Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
16
Closed
7
Calls
$1.34M
Puts
$1.18M
Net Calls
+$161K
Net Calls Change
+$297K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
State Street
Boston,
Massachusetts
| – | – | -11,450 | Closed |
|
52
UBS Group
Zurich,
Switzerland
| – | – | -6,643 | Closed |
|
53
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
| – | – | -6,000 | Closed |
|
|
NFG
54
Next Financial Group
Houston,
Texas
| – | – | -1,000 | Closed |
|
55
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|
|
SM
56
Sabby Management
Miami Beach,
Florida
| – | – | – | – |
|
|
RFM
57
Royal Fund Management
Lady Lake,
Florida
| $0 | 7 | – | – |
|
58
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 2 | – | – |
|